Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Parasit Vectors ; 17(1): 213, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38730500

ABSTRACT

BACKGROUND: Toxoplasma gondii is an obligate intracellular parasite that can lead to adverse pregnancy outcomes, particularly in early pregnancy. Previous studies have illustrated the landscape of decidual immune cells. However, the landscape of decidual immune cells in the maternal-fetal microenvironment during T. gondii infection remains unknown. METHODS: In this study, we employed single-cell RNA sequencing to analyze the changes in human decidual immune cells following T. gondii infection. The results of scRNA-seq were further validated with flow cytometry, reverse transcription-polymerase chain reaction, western blot, and immunofluorescence staining. RESULTS: Our results showed that the proportion of 17 decidual immune cell clusters and the expression levels of 21 genes were changed after T. gondii infection. Differential gene analysis demonstrated that T. gondii infection induced the differential expression of 279, 312, and 380 genes in decidual NK cells (dNK), decidual macrophages (dMφ), and decidual T cells (dT), respectively. Our results revealed for the first time that several previously unknown molecules in decidual immune cells changed following infection. This result revealed that the function of maternal-fetal immune tolerance declined, whereas the killing ability of decidual immune cells enhanced, eventually contributing to the occurrence of adverse pregnancy outcomes. CONCLUSIONS: This study provides valuable resource for uncovering several novel molecules that play an important role in the occurrence of abnormal pregnancy outcomes induced by T. gondii infection.


Subject(s)
Decidua , Pregnancy Outcome , Single-Cell Analysis , Toxoplasma , Toxoplasmosis , Female , Pregnancy , Humans , Decidua/immunology , Decidua/parasitology , Toxoplasmosis/immunology , Toxoplasmosis/parasitology , Toxoplasma/immunology , Gene Expression Profiling , Killer Cells, Natural/immunology , Macrophages/immunology , Macrophages/parasitology , Transcriptome , T-Lymphocytes/immunology
2.
J Alzheimers Dis Rep ; 8(1): 561-574, 2024.
Article in English | MEDLINE | ID: mdl-38746630

ABSTRACT

Background: Alzheimer's disease may be effectively treated with acupoint-based acupuncture, which is acknowledged globally. However, more research is needed to understand the alterations in acupoints that occur throughout the illness and acupuncture treatment. Objective: This research investigated the differences in acupoint microcirculation between normal mice and AD animals in vivo. This research also examined how acupuncture affected AD animal models and acupoint microcirculation. Methods: 6-month-old SAMP8 mice were divided into two groups: the AD group and the acupuncture group. Additionally, SAMR1 mice of the same month were included as the normal group. The study involved subjecting a group of mice to 28 consecutive days of acupuncture at the ST36 (Zusanli) and CV12 (Zhongwan) acupoints. Following this treatment, the Morris water maze test was conducted to assess the mice's learning and memory abilities; the acoustic-resolution photoacoustic microscope (AR-PAM) imaging system was utilized to observe the microcirculation in CV12 acupoint region and head-specific region of each group of mice. Results: In comparison to the control group, the mice in the AD group exhibited a considerable decline in their learning and memory capabilities (p < 0.01). In comparison to the control group, the vascular in the CV12 region and head-specific region in mice from the AD group exhibited a considerable reduction in length, distance, and diameter r (p < 0.01). The implementation of acupuncture treatment had the potential to enhance the aforementioned condition to a certain degree. Conclusions: These findings offered tangible visual evidence that supports the ongoing investigation into the underlying mechanisms of acupuncture's therapeutic effects.

3.
Commun Biol ; 7(1): 669, 2024 May 31.
Article in English | MEDLINE | ID: mdl-38822095

ABSTRACT

Myeloid-derived suppressor cells (MDSCs) play a crucial role in maintaining maternal-fetal tolerance by expressing some immune-suppressive molecules, such as indoleamine 2,3-dioxygenase (IDO). Toxoplasma gondii (T. gondii) infection can break the immune microenvironment of maternal-fetal interface, resulting in adverse pregnancy outcomes. However, whether T. gondii affects IDO expression in dMDSCs and the molecular mechanism of its effect are still unclear. Here we show, the mRNA level of IDO is increased but the protein level decreased in infected dMDSCs. Mechanistically, the upregulation of transcriptional levels of IDO in dMDSCs is regulated through STAT3/p52-RelB pathway and the decrease of IDO expression is due to its degradation caused by increased SOCS3 after T. gondii infection. In vivo, the adverse pregnancy outcomes of IDO-/- infected mice are more severe than those of wide-type infected mice and obviously improved after exogenous kynurenine treatment. Also, the reduction of IDO in dMDSCs induced by T. gondii infection results in the downregulation of TGF-ß and IL-10 expression in dNK cells regulated through Kyn/AhR/SP1 signal pathway, eventually leading to the dysfunction of dNK cells and contributing the occurrence of adverse pregnancy outcomes. This study reveals a novel molecular mechanism in adverse pregnancy outcome induced by T. gondii infection.


Subject(s)
Down-Regulation , Indoleamine-Pyrrole 2,3,-Dioxygenase , Killer Cells, Natural , Toxoplasmosis , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics , Female , Animals , Mice , Pregnancy , Toxoplasmosis/immunology , Toxoplasmosis/parasitology , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Toxoplasma/physiology , Decidua/immunology , Decidua/metabolism , Decidua/parasitology , Myeloid-Derived Suppressor Cells/immunology , Myeloid-Derived Suppressor Cells/metabolism , Humans , Mice, Inbred C57BL
4.
Heliyon ; 10(10): e30805, 2024 May 30.
Article in English | MEDLINE | ID: mdl-38813205

ABSTRACT

Background: Colpocleisis is one of traditional surgical procedures for elderly and frail women with advanced pelvic organ prolapse. The occurrence of de novo urinary incontinence following colpocleisis was considered to impair the postoperative quality of life. The incidence of de novo urinary incontinence after colpocleisis has been reported to be ranging from 6.6 % to 27 %. There was an absence of prospective large-sample study to investigate the accurate incidence of de novo urinary incontinence following colpocleisis and the impact on the quality of life till now. Purpose: s The primary objective was to report the incidence of de novo urinary incontinence after colpocleisis. The second objectives were to evaluate the long-term quality of life in patients with de novo urinary incontinence, and to conduct detailed pre- and post-operative evaluations of lower urinary tract symptoms. Methods: This prospective study included 253 patients with symptomatic pelvic organ prolapse who underwent colpocleisis between 2009 and 2021. De novo urinary incontinence was defined as the occurrence of urinary incontinence 3 months postoperatively. All patients were required to complete the Urinary Distress Inventory questionnaire and the Urinary Impact Questionnaire for the evaluation of patients' quality of life, and the Patient Global Impression of Improvement questionnaire for the evaluation of patients' satisfaction. Results: 245 patients (245/253, 96·8 %) completed the 3-month follow-up, and were included in the final analysis. The incidence of de novo urinary incontinence was 5.4 % (10/185). There was no significant difference in the Urinary Distress Inventory -6 scores (22.50 vs. 10.30, P = 0.276) or the subjective satisfaction rate (100 % vs. 98.9 %, P = 0.250) between the patients with or without de novo urinary incontinence at the long-term follow-up. The incidence of voiding difficulty was significantly reduced after colpocleisis (27.8 % vs. 0.0 %, P < 0.001). The patients' quality of life indicated by Urinary Distress Inventory-6 and Urinary Impact Questionnaire-7 scores were significantly improved postoperatively (26.27 vs. 13.39, and 19.13 vs. 6.05, P < 0.05). Conclusion: The incidence of de novo urinary incontinence after colpocleisis was very low. Patients' quality of life, and low urinary tract symptoms were significantly improved after colpocleisis.

5.
Mol Biol Rep ; 51(1): 454, 2024 Mar 27.
Article in English | MEDLINE | ID: mdl-38536516

ABSTRACT

Dysregulation of oxidative stress serves as a pivotal predisposing or exacerbating factor in the intricate development of numerous pathological processes and diseases. In recent years, substantial evidence has illuminated the crucial role of reactive oxygen species (ROS) in many fundamental cellular functions, including proliferation, inflammation, apoptosis, and gene expression. Notably, producing free radicals within ROS profoundly impacts a wide range of biomolecules, such as proteins and DNA, instigating cellular damage and impairing vital cellular functions. Consequently, oxidative stress emerges as a closely intertwined factor across diverse disease spectra. Remarkably, the pathogenesis of several eye diseases, including age-related macular degeneration, glaucoma, and diabetic retinopathy, manifests an intrinsic association with oxidative stress. In this comprehensive review, we briefly summarize the recent progress in elucidating the intricate role of oxidative stress in the development of ophthalmic diseases, shedding light on potential therapeutic avenues and future research directions.


Subject(s)
Antioxidants , Glaucoma , Humans , Reactive Oxygen Species/metabolism , Antioxidants/metabolism , Eye/metabolism , Oxidative Stress , Glaucoma/drug therapy
6.
Article in English | MEDLINE | ID: mdl-38243928

ABSTRACT

BACKGROUND: Curcumin has been reported to have anti-hepatocellular carcinoma (HCC) effects, but the underlying mechanism is not well known. OBJECTIVES: To investigate whether membrane-associated RING-CH 1 (MARCH1) is involved in the curcumin-induced growth suppression in HCC and its underlying molecular mechanism. A few recent patents for curcumin for cancer are also reviewed in this article. METHODS: The effect of curcumin on growth inhibition of HCC cells was analyzed through in vitro and in vivo experiments, and the expression levels of MARCH1, Bcl-2, VEGF, cyclin B1, cyclin D1, and JAK2/STAT3 signaling molecules were measured in HCC cells and the xenograft tumors in nude mice. Cell transfection with MARCH1 siRNAs or expression plasmid was used to explore the role of MARCH1 in the curcumin-induced growth inhibition of HCC cells. RESULTS: Curcumin inhibited cell proliferation, promoted apoptosis, and arrested the cell cycle at the G2/M phase in HCC cells with the decrease of Bcl-2, VEGF, cyclin B1, and cyclin D1 expression as well as JAK2 and STAT3 phosphorylation, resulting in the growth suppression of HCC cells. MARCH1 is highly expressed in HCC cells, and its expression was downregulated after curcumin treatment in a dose-dependent manner. The knockdown of MARCH1 by siRNA decreased the phosphorylation levels of JAK2 and STAT3 and inhibited the growth of HCC cells. In contrast, opposite results were observed when HCC cells overexpressed MARCH1. A xenograft tumor model in nude mice also showed that curcumin downregulated MARCH1 expression and decelerated the growth of transplanted HCC with the downregulation of JAK2/STAT3 signaling and functional molecules. The ADC value of MRI analysis showed that curcumin slowed down the progression of HCC. CONCLUSION: Our results demonstrated that curcumin may inhibit the activation of JAK2/STAT3 signaling pathway by downregulating MARCH1 expression, resulting in the growth suppression of HCC. MARCH1 may be a novel target of curcumin in HCC treatment.

7.
Acta Psychol (Amst) ; 241: 104091, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38016214

ABSTRACT

The purpose of this study was to investigate the impact of need fulfillment given by opposite-sex friends (NFOF) on breakup considerations, the mediating role of love commitment in this relationship, and the moderating role of need fulfillment given by romantic partners (NFRP). A total of 334 unmarried individuals in romantic relationships from Northwest China were invited to participate in the study. The findings revealed the following: (1) NFOF significantly and positively predicted breakup considerations. (2) This relationship is mediated by love commitment (3) The association between NFOF and breakup considerations was moderated by NFRP (in terms of the first mediation path). Specifically, those who hold higher levels of NFRP are appreciably buffered against the negative impact of NFOF on love commitment. These findings emphasize the crucial role of NFOF and NFRP in shaping love commitment and breakup considerations. Moreover, our research has important realistic implications: NFOF, as a trigger, has a negative effects the quality of romantic relationships and leads to breakup considerations. And, the key to maintaining a romantic relationship is to focus on their partners' need fulfillment as much as possible and increasing the level of their love commitment.


Subject(s)
Friends , Interpersonal Relations , Humans , Sexual Behavior , Love , Negotiating
8.
Sci Bull (Beijing) ; 68(20): 2434-2447, 2023 10 30.
Article in English | MEDLINE | ID: mdl-37714805

ABSTRACT

Pelvic organ prolapse (POP) seriously affects a woman's quality of life, and the treatment complications are severe. Although new surgical treatments are being developed, the host tissue responses and safety need to be evaluated in preclinical trials. However, there is a lack of suitable animal models, as most quadrupeds exhibit different structural and pathological changes. In this study, 72 elderly rhesus macaques (Macaca mulatta) were physically examined, and the incidence of spontaneous POP was similar to that in humans. The vaginal wall from five control monkeys and four monkeys with POP were selected for further analysis. Verhoeff-van Gieson staining showed that elastin content decreased significantly in monkeys with POP compared with control samples. Immunohistological staining revealed that the smooth muscle bundles in monkey POP appeared disorganized, and the number of large muscle bundles decreased significantly. The collagen I/III ratio in monkey POP also significantly decreased, as revealed by Sirius Red staining. These histological and biochemical changes in monkeys with POP were similar to those in humans with POP. Moreover, we generated a single-cell transcriptomic atlas of the prolapsed monkey vagina. Cross-species analysis between humans and monkeys revealed a comparable cellular composition. Notably, a differential gene expression analysis determined that dysregulation of the extracellular matrix and an immune disorder were the conserved molecular mechanisms. The interplay between fibroblasts and macrophages contributed to human and monkey POP. Overall, this study represents a comprehensive evaluation of spontaneous POP in rhesus macaques and demonstrates that monkeys are a suitable animal model for POP research.


Subject(s)
Pelvic Organ Prolapse , Quality of Life , Female , Animals , Humans , Aged , Macaca mulatta/metabolism , Pelvic Organ Prolapse/veterinary , Extracellular Matrix/metabolism , Collagen Type I/metabolism
10.
J Immunol Res ; 2023: 8643548, 2023.
Article in English | MEDLINE | ID: mdl-37032654

ABSTRACT

Purpose: It is well documented that angiotensin II (Ang II) elevation promotes apoptosis of podocytes in vivo and vitro, but the potential mechanism is still oscular. The current study is aimed at probing into the assignment of cysteine-rich protein 61 (Cyr61) in Ang II-induced podocyte apoptosis. Methods: Podocytes were treated with Ang II (10-6 mol/L) for 48 hours to establish an injury model in vitro. Western blot assays were detected the expression of Cyr61, Cyt-c, Bax, and Bcl-2. Gene microarray was used to analyze the expression of mRNAs after treatment with Ang II. CRISPR/Cas9 technology was used to knock down Cyr61 and overexpress TXNIP gene, respectively. Results: The expression of Cyr61, TXNIP, Cyt-c, and Bax in podocytes treated with Ang II were upregulated, but the expression and apoptotic rates of Bcl-2 in podocytes were inhibited. The level of the above factors was not significantly different after the knockdown of Cyr61 with Ang II in podocytes. In Ang II group, when knocked down Cyr61, the expressed level of TXNIP, Cyt-c, and Bax was diminished after Ang II treatment; interestingly Bcl-2 expression and podocyte apoptotic rate were reduced. Under the stimulation of Ang II, the expression of Cyt-c and Bax were growing, whereas Bcl-2 was reduced, and the apoptotic rates were higher in the TXNIP overexpression group. Cyt-c and Bax were put on, whereas that of Bcl-2 was to be cut down when the Cyr61 was knockdown, and the apoptotic rates were gained in the TXNIP overexpression+Cyr61 knockdown group. Conclusions: The results of the study extrapolate that Cyr61 plays a dominant role in Ang II-induced podocyte apoptosis. Additionally, Cyr61 may mediate the Ang II-induced podocyte apoptosis by promoting the expression of TNXIP.


Subject(s)
Angiotensin II , Podocytes , Up-Regulation , Angiotensin II/pharmacology , Podocytes/metabolism , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism , Apoptosis/genetics
12.
Thorac Cancer ; 13(15): 2235-2247, 2022 08.
Article in English | MEDLINE | ID: mdl-35811256

ABSTRACT

BACKGROUND: Lung cancer (LC) is one of the most common cancers and a leading cause of cancer-related deaths worldwide. In many pathological conditions, particularly in the tumor microenvironment, cells and tissues frequently exist in a hypoxic state. Here, we evaluated Itchy E3 ubiquitin protein ligase (ITCH) expression in LC cells following hypoxia treatment. METHODS: LC cell lines were treated with hypoxic condition. Cell migration, invasion, inflammation, reactive oxygen species (ROS) production, and apoptosis of LC cells were determined by wound healing assay, Transwell invasive assay, ELISA, DCFH-DA staining, and flow cytometry, respectively. qPCR and WB were used to determine the expression of ITCH and TXNIP. Co-IP was performed to assess the interaction between ITCH and TXNIP. RESULTS: ITCH expression was downregulated in LC cells under hypoxic conditions. Next, LC cells were subjected to hypoxic conditions and changes in cell viability and metastasis were determined. Hypoxic conditions resulted in increased migration and invasion abilities of LC cells. Intracellular reactive oxygen species (ROS) production, inflammation, and apoptosis were also promoted by hypoxia. We found that ITCH overexpression led to the proteasomal degradation of thioredoxin-interacting protein (TXNIP), whereas the expression of the ITCH C830A mutant did not affect TXNIP levels in LC cells. The gain-of-function experiment demonstrated that migration, invasion, ROS generation, inflammation, and apoptosis of hypoxia-conditioned LC cells were ameliorated by ITCH overexpression, whereas the ITCH C830A mutant did not cause any changes in these phenotypes. Furthermore, the contribution of TXNIP knockdown and ITCH overexpression to the hypoxia-induced features in LC cells with ITCH C830A was found to be similar. CONCLUSION: Our results suggest a novel mechanism underlying the changes in ITCH-mediated malignant phenotypes of hypoxia-conditioned LC cells via TXNIP.


Subject(s)
Lung Neoplasms , Ubiquitin-Protein Ligases , Carrier Proteins/genetics , Humans , Hypoxia/complications , Inflammation , Lung Neoplasms/genetics , Reactive Oxygen Species/metabolism , Tumor Microenvironment , Ubiquitin-Protein Ligases/genetics , Ubiquitin-Protein Ligases/metabolism
13.
Expert Opin Drug Saf ; 21(10): 1329-1336, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35315301

ABSTRACT

BACKGROUND: Dropped head syndrome (DHS) is a relatively rare disease, and its potential relationship with drug exposure has been postulated but is poorly understood. RESEARCH DESIGN AND METHODS: This retrospective study evaluated the adverse event reports of DHS in the FDA adverse event reporting system (FAERS) between 1 January 2004, to 31 March 2021. Empirical Bayes Geometric Means (EBGM) and the lower 95% one-sided CI of EBGM were calculated to identify disproportionate reporting of DHS associated with drugs. In addition, published case reports were identified in the PubMed, Embase and Cochrane Library up to 5 August 2021. RESULTS: There were 193 reports of DHS in the FAERS, in which nervous system agents were most frequently reported, followed by antineoplastic and immunomodulating agents. Pramipexole, ropinirole, levodopa, pregabalin, rotigotine, cisplatin, imatinib and botulinum toxin showed disproportionality signal based each on more than 5 cases. Ten published DHS case reports were identified in the literature. CONCLUSION: Our study provides a more explicit profile on the occurrences and characteristics of DHS associated with drugs by analyzing the FAERS data and indicates that exposure of certain drug showed disproportionality signal with the increased DHS risk, which suggests the importance of further clinical and observational investigations.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Muscular Diseases , United States , Humans , Adverse Drug Reaction Reporting Systems , Bayes Theorem , Retrospective Studies , Drug-Related Side Effects and Adverse Reactions/epidemiology , Drug-Related Side Effects and Adverse Reactions/etiology , United States Food and Drug Administration , Databases, Factual , Pharmacovigilance
14.
Environ Sci Pollut Res Int ; 29(18): 27339-27351, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34978031

ABSTRACT

Although green mergers and acquisitions (M&A) emerged recently as corporate green management actions, whether they can prompt corporations to achieve green transformation is unclear, as little is known about how green M&A affects strategic decisions on corporate environmental behavior. Based on legitimacy theory, we analyze Chinese heavy-polluting firms listed in the Shanghai and Shenzhen Stock Exchanges from 2009 to 2017 to explore the impact of green M&A on corporate environmental governance. Results show that green M&A has a positive impact on corporate environmental management. Specifically, we find that the positive relationship between green M&A and corporate environmental governance is strong in firms in localities under considerable media scrutiny, as such firms face increased legitimacy benefits and illegitimacy penalties. Conversely, state-owned enterprises (SOEs) weaken this relationship, as such enterprises have natural political connections to undermine legitimacy benefits and avoid illegitimacy penalties. Thus, we argue that media scrutiny and SOEs influence the likelihood of an organization to implement green M&A as a sincere substantive strategic action. Finally, we summarize the green M&A implementation of an organization in environmental governance as a sincere green action rather than hypocritical greenwashing. Furthermore, we make contributions to legitimacy theory and the corporate environmental governance literature.


Subject(s)
Conservation of Natural Resources , Environmental Policy , China , Organizations , Probability
15.
Antioxidants (Basel) ; 12(1)2022 Dec 21.
Article in English | MEDLINE | ID: mdl-36670874

ABSTRACT

Aconitase 1 (ACO1) links oxidative stress and iron accumulation in Parkinson's disease (PD). ACO1 loses its aconitase activity and turns into iron regulatory protein 1 (IRP1) upon oxidative stress. IRP1 plays an important role in the accumulation of intracellular iron. Baicalein is a flavonoid isolated from the roots of Scutellaria baicalensis. The present results show that baicalein could bind to ACO1 and protect its isoform from the oxidative stress induced by reactive oxygen species (ROS) and reactive nitrogen species (RNS). Furthermore, baicalein promoted aconitase activity and inhibited IRP1 activation in rotenone-induced PD models. Additionally, baicalein decreased the hydroxyl radicals generated by iron. In conclusion, baicalein attenuated iron accumulation and iron-induced oxidative stress in the brain of PD rats by protecting ACO1.

16.
Sankhya B (2008) ; 83(2): 374-396, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34924732

ABSTRACT

Clinical studies and trials on periodontal disease (PD) generate a large volume of data collected at various tooth locations of a subject. However, they present a number of statistical complexities. When our focus is on understanding the extent of extreme PD progression, standard analysis under a generalized linear mixed model framework with a symmetric (logit) link may be inappropriate, as the binary split (extreme disease versus not) maybe highly skewed. In addition, PD progression is often hypothesized to be spatially-referenced, i.e. proximal teeth may have a similar PD status than those that are distally located. Furthermore, a non-ignorable quantity of missing data is observed, and the missingness is non-random, as it informs the periodontal health status of the subject. In this paper, we address all the above concerns through a shared (spatial) latent factor model, where the latent factor jointly models the extreme binary responses via a generalized extreme value regression, and the non-randomly missing teeth via a probit regression. Our approach is Bayesian, and the inferential framework is powered by within-Gibbs Hamiltonian Monte Carlo techniques. Through simulation studies and application to a real dataset on PD, we demonstrate the potential advantages of our model in terms of model fit, and obtaining precise parameter estimates over alternatives that do not consider the aforementioned complexities.

17.
Hum Cell ; 34(6): 1800-1811, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34374933

ABSTRACT

Long non-coding RNAs (LncRNAs) have recently emerged as vital regulators in the development and progression of hepatocellular carcinoma (HCC), providing new opportunities as novel therapeutic targets. Here we identified the lncRNA NIFK-AS1 as being highly expressed in HCC tissues and cells and showed this up-regulation resulted from METTL3-dependent m6A methylation. Functionally, knockdown of NIFK-AS1 inhibited the proliferation, colony formation, migration, and invasion of HCC cells. Moreover, these effects were elicited though AKT1 and we uncovered a ceRNA network involving an NIFK-AS1/miR-637/AKT1 axis with downstream effects on HCC progression involving regulation of MMP-7 and MMP-9 expression. From the clinical perspective, we showed that knockdown of NIFK-AS1 sensitized HCC cells to sorafenib through the up-regulation of the drug transporters OATP1B1 and OATP1B3. Clinical investigations showed HCC patients with low NIFK-AS1 expression benefited from sorafenib therapy and this phenomenon was reproduced in patient-derived tumor xenograft models (PDX) comparing HCC with low and high expression of NIFK-AS1. Taken together, these results suggest an essential role for NIFK-AS1 in HCC progression and promote NIFK-AS1 as a new therapeutic target and predictor of sorafenib benefit in HCC patients.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Drug Resistance, Neoplasm/genetics , Gene Expression Regulation, Neoplastic/genetics , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/physiology , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Methyltransferases/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/physiology , Sorafenib/pharmacology , Up-Regulation/genetics , Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/metabolism , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , Disease Progression , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Liver Neoplasms/drug therapy , Liver Neoplasms/metabolism , Methylation , Molecular Targeted Therapy , Neoplasm Invasiveness/genetics , Nuclear Proteins/metabolism , RNA, Long Noncoding/genetics , Sorafenib/therapeutic use , Up-Regulation/physiology
18.
Acta Pharm Sin B ; 11(7): 1903-1913, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34386327

ABSTRACT

Nicotinic α4ß2 receptor antagonists have drawn increasing attention in the development of new antidepressants. In this study, we aimed to investigate the protective effect of VMY-2-95, the new selective antagonist of α4ß2 nicotinic acetylcholine receptor (nAChR) on corticosterone (CORT) injured mice and cellular models. Fluoxetine was applied as a positive control, and the effects of VMY-2-95 were investigated with three different doses or concentrations (1, 3, 10 mg/kg in mice, and 0.003, 0.03, 0.1 µmol/L in cells). As a result, VMY-2-95 showed significant antidepressant-like effects in the CORT injured mice by improving neuromorphic function, promoting hippocampal nerve proliferation, and regulating the contents of monoamine transmitters. Meanwhile, VMY-2-95 exhibited protective effects on cell viability, cell oxidant, cell apoptosis, and mitochondrial energy metabolism on corticosterone-impaired SH-SY5Y cells. Also, the PKA-CREB-BDNF signaling pathway was up-regulated by VMY-2-95 both in vitro and in vivo, and pathway blockers were also combined with VMY-2-95 to verify the effects furtherly. Therefore, we preliminarily proved that VMY-2-95 had protective effects in depressed mice and SH-SY5Y cells against injuries induced by corticosterone. This work indicated that the application of VMY-2-95 is a potential pharmacological solution for depression. This study also supported the development of α4ß2 nAChR antagonists towards neuropsychiatric dysfunctions.

19.
Molecules ; 26(9)2021 May 03.
Article in English | MEDLINE | ID: mdl-34063645

ABSTRACT

Drug combinations have been the hotspot of the pharmaceutical industry, but the promising applications are limited by the unmet solubility and low bioavailability. In this work, novel cocrystals, consisting of two antithrombotic drugs with poor solubility and low bioavailability in vivo, namely, apixaban (Apx) and quercetin (Que), were developed to discover a potential method to improve the poor solubility and internal absorption of the drug combination. Compared with Apx, the dissolution behavior of Apx-Que (1:1) and Apx-Que-2ACN (1:1:2) was enhanced significantly, while the physical mixture of the chemicals failed to exhibit the advantages. The dissolution improvements of Apx-Que-2ACN could be explained by the fact that the solid dispersion-like structure and column-shaped cage of Que accelerated the access of the solvent to the inner layer of Apx. The fracture of the hydrogen bonds of Apx, which was the joint of the adjacent Que chains, facilitated the break-up of the structures. Besides, the bioavailability of Apx-Que was increased compared with the physical mixture and Apx, and Apx-Que remained stable in high temperature and illumination conditions. Therefore, a drug-drug cocrystal of two antithrombotic agents with poor solubility was developed, which exhibited greatly improved solubility, bioavailability and superior stability, indicating a novel method to overcome the shortages of drug combination.


Subject(s)
Crystallization , Drug Combinations , Pyrazoles/pharmacology , Pyridones/pharmacology , Quercetin/pharmacology , Solvents , Animals , Biological Availability , Calorimetry, Differential Scanning , Chromatography, High Pressure Liquid , Fibrinolytic Agents/pharmacology , Hydrogen Bonding , Male , Pharmaceutical Preparations , Powders , Pyrazoles/chemistry , Pyridones/chemistry , Quercetin/chemistry , Rats , Rats, Sprague-Dawley , Solubility , Temperature , Thermogravimetry , X-Ray Diffraction
20.
Biomed Pharmacother ; 140: 111556, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34087694

ABSTRACT

BACKGROUND: Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder in the world. In addition to motor symptoms, a variety of non-motor symptoms seriously affect the life quality of PD patients. Baicalein, a flavonoid extracted from the herb Scutellaria baicalensis Georgi, exhibits anti-PD activity through alleviation of its motor symptoms. However, its effects on non-motor symptoms were barely reported. This study aimed to investigate the therapeutic effects of baicalein on PD-related depression. METHODS: After a 2-week injection of rotenone, mice with PD-related depression behavior were selected, divided into three groups, and administrated saline, baicalein, or madopar orally for four weeks. Behavior, neuroinflammation, neurotransmitters, and synaptic plasticity were evaluated. RESULTS: Our results showed that 4-week baicalein treatment significantly alleviated the depression-like behavior in the rotenone-induced mice model. Repeated baicalein treatment reduced α-synuclein aggregation, inhibited neuroinflammation, and maintained neurotransmitters homeostasis. Moreover, we found that baicalein treatment could remarkably protect the synaptic plasticity and activate the BDNF/TrkB/CREB pathway in the PD-related depression mice model. As traditional dopamine replacement therapy unleashed few effects on depression-like symptom amelioration and synaptic function protection, baicalein might be a more appropriate choice for PD-related depression. CONCLUSIONS: The current results suggested that baicalein could act as a treatment for PD-related depression.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Depression/drug therapy , Flavanones/pharmacology , Membrane Glycoproteins/metabolism , Parkinson Disease/drug therapy , Protein-Tyrosine Kinases/metabolism , Rotenone/adverse effects , Animals , Depression/metabolism , Disease Models, Animal , Flavonoids/pharmacology , Homeostasis/drug effects , Inflammation/drug therapy , Inflammation/metabolism , Male , Mice , Mice, Inbred C57BL , Neuronal Plasticity/drug effects , Neuroprotective Agents/pharmacology , Neurotransmitter Agents/metabolism , Parkinson Disease/etiology , Parkinson Disease/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...